Shortlist by what you need
Start here if you know why you are leaving Rayscape.
Want the closest match?
AZmedMost similar to Rayscape in what it does, its category and its price.
Visit (opens AZmed in a new tab)Want the best rated?
ArteraRated 4.4 out of 5 in our review, against 3.7 for Rayscape.
Visit (opens Artera in a new tab)
At a glance
Green means better than Rayscape, red means worse. Prices are starting prices per month.
| Tool | Our rating | Starts at | Free plan | Best for | Compare |
|---|---|---|---|---|---|
| 3.7 | Not listed | No | FDA-cleared AI that reads chest X-rays and lung CTs for 148+ pathologies, trained on 42M+ medical images - detects, measures, and tracks pulmonary nodules from 3 to 30mm. | ||
| 4.4+0.7 | Not listed | No | FDA-cleared AI radiology suite that flags fractures and chest abnormalities on standard X-rays. | vs Rayscape | |
| 3.9+0.2 | Not listed | No | Deep-learning chest X-ray analysis (CXR-AI) sped radiologist interpretation over 20% in early trials - the first U.S. imaging AI company approved to commercialize in Japan. | vs Rayscape | |
| 3.3−0.4 | Not listed | No | AI reads 3D low-dose CT scans and risk-stratifies lung nodules (AUROC 0.94, trained on 100,000+ scans) - already deployed across underserved health centers in 4 states. | vs Rayscape | |
| 4.1+0.4 | Not listed | No | Imaging biomarkers for lung and heart clinical trials, from a Cambridge deep-learning lab. | vs Rayscape | |
| 4.4+0.7 | Not listed | No | FDA-cleared multimodal AI that reads biopsy images and clinical data to guide cancer therapy decisions. | vs Rayscape | |
| 3.9+0.2 | Not listed | No | Houston healthcare AI company with an FDA-cleared radiation therapy dose-planning tool and transplant and sinus-imaging products. | vs Rayscape | |
| 4.1+0.4 | Not listed | No | Digital pathology AI co-pilot from Memorial Sloan Kettering researchers, acquired by Tempus in 2025 | vs Rayscape | |
| 4.2+0.5 | Not listed | No | Reads dental radiographs to flag pathology, with practice analytics and claims tooling around it. | vs Rayscape |
The alternatives in detail
In order of how closely each one matches Rayscape.

AZmed
4.4Not listed
vs Rayscape+0.7
FDA-cleared AI radiology suite that flags fractures and chest abnormalities on standard X-rays.
- FDA-cleared fracture, joint effusion, and dislocation detection (AZtrauma)
- FDA-cleared chest X-ray triage for nodules, pneumothorax, and pleural effusion (AZchest)
- Pediatric and adult population coverage
Multiple FDA clearances rather than a single narrow approval
No public pricing; only reachable through a sales demo

Enlitic
3.9Not listed
vs Rayscape+0.2
Deep-learning chest X-ray analysis (CXR-AI) sped radiologist interpretation over 20% in early trials - the first U.S. imaging AI company approved to commercialize in Japan.
- CXR-AI - deep-learning chest X-ray abnormality detection
- ENDEX - AI-based medical image data standardization
- Curie platform for real-world evidence data infrastructure
Regulatory approval (Japan) is a concrete, third-party-verifiable claim
Enterprise healthcare infrastructure - not accessible to individual practitioners or consumers

Oatmeal Health
3.3Not listed
vs Rayscape−0.4
AI reads 3D low-dose CT scans and risk-stratifies lung nodules (AUROC 0.94, trained on 100,000+ scans) - already deployed across underserved health centers in 4 states.
- AI risk-stratification of lung nodules from 3D low-dose CT
- AUROC 0.94, trained on 100,000+ CT scans
- Complements established Lung-RADS protocols
Real, verifiable clinical deployment, not just a pilot announcement
LungAI is an investigational device and has not yet been cleared by the FDA - a 510(k) submission is targeted for Q1 2026

Qureight
4.1Not listed
vs Rayscape+0.4
Imaging biomarkers for lung and heart clinical trials, from a Cambridge deep-learning lab.
- Deep-learning lung imaging biomarkers Lung8, Air8 and Fibr8
- Glass8 and Vascul8 for vascular and parenchymal measures
- Central reads and endpoint discovery for trials
Consistent measurement reduces the variability that costs trial power
No published pricing; sold to trial sponsors

Artera
4.4Not listed
vs Rayscape+0.7
FDA-cleared multimodal AI that reads biopsy images and clinical data to guide cancer therapy decisions.
- Multimodal AI trained on digitized biopsy images paired with clinical data
- FDA De Novo authorization for the ArteraAI Prostate Test
- FDA clearance for ArteraAI Breast digital pathology risk stratification
Regulatory clearance (FDA De Novo, NCCN guideline inclusion) beyond most AI health startups
Not a self-serve software product; access runs through labs, clinicians, and insurance billing

InformAI
3.9Not listed
vs Rayscape+0.2
Houston healthcare AI company with an FDA-cleared radiation therapy dose-planning tool and transplant and sinus-imaging products.
- RadOncAI radiation therapy dose planning with FDA 510(k) clearance
- Focus on head and neck cancer treatment planning
- TransplantAI donor-recipient informatics for transplant decisions
One product has FDA 510(k) clearance, a meaningful regulatory milestone
Only RadOncAI is described as cleared; the other products are research or in development

Paige
4.1Not listed
vs Rayscape+0.4
Digital pathology AI co-pilot from Memorial Sloan Kettering researchers, acquired by Tempus in 2025.
- Paige Alba AI co-pilot for digital pathology tissue-slide analysis
- Cancer diagnosis, tissue subtyping, and molecular biomarker discovery support
- Founded in 2017 by researchers from Memorial Sloan Kettering Cancer Center
Research pedigree from Memorial Sloan Kettering lends real clinical credibility
Enterprise-only pricing requires a sales conversation before evaluation

Pearl
4.2Not listed
vs Rayscape+0.5
Reads dental radiographs to flag pathology, with practice analytics and claims tooling around it.
- Pathology detection in 2D radiographs
- CBCT review for specialists and general dentists
- Practice performance analytics
A consistent second read on every image, not a variable one
Pricing page 404s and no figure is published anywhere
FAQ
Questions people ask
Is Rayscape free?
Rayscape does not list a free plan. Check its pricing page for current plans.
How did you pick these alternatives?
We match tools on what they do, their category and their price, using the details in our directory. Ratings come from our reviews and reader reviews.
